Literature DB >> 27054394

Emergence of nail lacquers as potential transungual delivery system in the management of onchomycosis.

Purnima Kataria1, Gajanand Sharma2, Kanika Thakur2, Vikas Bansal1, Sunil Dogra3, Om Prakash Katare2.   

Abstract

INTRODUCTION: Onchomycosis is the most common nail fungal disease afflicting toes and fingers with a high recurrence rate. The disease is caused by various types of fungi ranging from dermatophyte to non-dermatophyte, making it difficult to eradicate. AREAS COVERED: The present article focuses on the emergence of nail lacquers as prospective transungual delivery systems for the treatment of mild-to-moderate onchomycosis. Updates regarding emerging nail lacquers, research progress in terms of clinical studies and patents for better understanding of the disease are provided. Finally, the characterization techniques for the assessment of drug concentration in different layers of nail are reviewed. EXPERT OPINION: The conventional topical delivery systems have failed to improve nail adhesion and drug absorption due to the highly keratinized hydrophilic structure of nail which obstructs the passage of drugs. The surgical therapy systems are painful and invasive while systemic therapy produces serious side effects and a high degree of relapse. These issues have led to the advent of nail lacquers. Nail lacquers have an immense potential to improve nail adhesion as well as bioavailability. However, the nail barrier is still a challenge in imparting complete cure. Several novel approaches are being developed in order to offer better therapeutic action.

Entities:  

Keywords:  Nail lacquers; nail; onchomycosis; topical; transungual drug delivery

Mesh:

Substances:

Year:  2016        PMID: 27054394     DOI: 10.1080/17425247.2016.1174691

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  2 in total

1.  Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.

Authors:  Deepa Dehari; Abhishesh Kumar Mehata; Vishnu Priya; Dharmnath Parbat; Deepak Kumar; Anand Kumar Srivastava; Sanjay Singh; Ashish Kumar Agrawal
Journal:  AAPS PharmSciTech       Date:  2022-06-24       Impact factor: 4.026

2.  Onychomycosis Unresponsive to Antifungals: Etiology and Treatment with a New Direct Technique.

Authors:  Fatma Gülru Erdogan; Dilsun Yıldırım; Gül Aslıhan Çakır Akay
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.